Expression of interleukin-18 in the lung after endotoxemia or hemorrhage-induced acute lung injury

被引:28
作者
Arndt, PG [1 ]
Fantuzzi, G [1 ]
Abraham, E [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Pulm & Crit Care Med, Denver, CO 80262 USA
关键词
D O I
10.1165/ajrcmb.22.6.3832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hemorrhage and endotoxemia are important risk factors for the development of acute lung injury. Interleukin (IL)-18 is a recently described cytokine released in its mature, active form after pro-IL-18 is cleaved by the IL-1 converting enzyme (ICE). IL-18 has multiple immunomodulating properties, including induction of interferon-gamma (IFN-gamma), IL-1 beta, tumor necrosis factor-a, and intercellular adhesion molecule-1. To examine the possible involvement of IL-18 in acute lung injury, we examined its expression, as well as that of IFN-gamma, IL-12, and ICE, using murine hemorrhage or endotoxemia models. The amounts of IL-18 messenger RNA (mRNA) increased in the lung after hemorrhage or endotoxemia. However, only endotoxemia was associated with elevations in lung and plasma concentrations of IL-18 protein. ICE expression was increased in the lungs after endotoxemia but not after hemorrhage. Although IFN-gamma expression increased in the lungs after hemorrhage or endotoxemia, elevations in lung IL-12 mRNA levels were found only after endotoxemia. These results indicate that hemorrhage and endotoxemia induce different patterns of immunomodulatory cytokine expression in the lungs. In particular, differences in the expression of ICE after hemorrhage or endotoxemia may affect generation of the active forms of downstream cytokines, including IL-18. IFN-gamma expression in the lungs after hemorrhage appears to occur through a pathway independent of IL-12 and IL-18. IL-18 may play a role in modulating the development of acute lung injury after endotoxemia but not after hemorrhage.
引用
收藏
页码:708 / 713
页数:6
相关论文
共 43 条
  • [1] PHOSPHATIDIC-ACID SIGNALING MEDIATES LUNG CYTOKINE EXPRESSION AND LUNG INFLAMMATORY INJURY AFTER HEMORRHAGE IN MICE
    ABRAHAM, E
    BURSTEN, S
    SHENKAR, R
    ALLBEE, J
    TUDER, R
    WOODSON, P
    GUIDOT, DM
    RICE, G
    SINGER, JW
    REPINE, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 569 - 575
  • [2] Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation
    Abraham, E
    Kaneko, DJ
    Shenkar, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (01) : L1 - L8
  • [3] ABRAHAM E, 1994, CLIN EXP IMMUNOL, V98, P29
  • [4] Ahn HJ, 1997, J IMMUNOL, V159, P2125
  • [6] HIGH-LEVELS OF INTERLEUKIN-8 IN THE BLOOD AND ALVEOLAR SPACES OF PATIENTS WITH PNEUMONIA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME
    CHOLLETMARTIN, S
    MONTRAVERS, P
    GIBERT, C
    ELBIM, C
    DESMONTS, JM
    FAGON, JY
    GOUGEROTPOCIDALO, MA
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4553 - 4559
  • [7] Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS
    CholletMartin, S
    Jourdain, B
    Gibert, C
    Elbim, C
    Chastre, J
    GougerotPocidalo, MA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 594 - 601
  • [8] Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
    Coughlin, CM
    Salhany, KE
    Wysocka, M
    Aruga, E
    Kurzawa, H
    Chang, AE
    Hunter, CA
    Fox, JC
    Trinchieri, G
    Lee, WMF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) : 1441 - 1452
  • [9] Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1β-converting enzyme (Caspase-1)-deficient mice
    Fantuzzi, G
    Puren, AJ
    Harding, MW
    Livingston, DJ
    Dinarello, CA
    [J]. BLOOD, 1998, 91 (06) : 2118 - 2125
  • [10] Adult respiratory distress syndrome: A systematic overview of incidence and risk factors
    Garber, BG
    Hebert, PC
    Yelle, JD
    Hodder, RV
    McGowan, J
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (04) : 687 - 695